BOTHELL, Wash., March 28 /PRNewswire/ — Microvision, Inc. (Nasdaq: MVIS) today announced that as a result of successful laboratory tests, Stryker
Leibinger (a division of Stryker Corporation (NYSE: SYK)) will purchase
10 Microvision’s Nomad wearable display systems for integration in a medical
The specific application for the Nomad system in the Stryker Navigation
System will remain confidential until product launch this fall; however, both
companies believe the application will assist in reducing surgical time and
improving patient outcomes.
Stryker Leibinger has been evaluating Microvision Nomad prototypes for a
range of potential medical applications since early 1999 as an unannounced
medical partner. The success of these evaluations has resulted in an initial
commitment to 10 systems intended for clinical evaluations.
Jerry Culp, technical director, advanced technology development at Stryker
Leibinger said, “We are pleased with the evaluations of the Nomad beta
displays. We anticipated that the capabilities of the Nomad display would
provide a dramatically enhanced alternative visualization tool in the surgical
suite. The result is that surgeons will be able to access data overlaid on
their direct line of sight. This augmented reality has the potential to be
extremely valuable for the surgeon and provides a unique performance feature
that other display technologies have been unable to deliver.
“Our initial commitment to purchase Microvision’s Nomad display is a
strong endorsement for the potential that we see with this valuable
Rick Rutkowski, Microvision president and CEO said, “Stryker is a world
leader in the development, manufacture and marketing of highly innovative
medical products and instruments. It has a superior reputation in the medical
community for delivering outstanding solutions that meet the needs of their
customers, and improve the standard of patient care. As we move toward
commercial launch of Nomad this year, this purchase commitment from our
medical partner is a significant statement about Nomad’s superior performance
and a strong indication of future market development. We will continue to
align ourselves with companies like Stryker who are proven leaders in their
target markets. We value their commitment and trust, and look forward to a
long and profitable relationship together.”
Headquartered in Bothell, Wash., Microvision, Inc. is the developer of the
patented retinal scanning display technology and a world leader in micro
miniature optical scanning technology for display and imaging applications.
The company’s technology has application in a broad range of military,
medical, industrial, professional and consumer information products.
Additional information can be found at the company’s Web site at
NOTE: Nomad and retinal scanning display are trademarks of Microvision, Inc.
The information set forth in this release includes “forward-looking
statements” within the meaning of Section 21E of the Securities Exchange Act
of 1934, as amended, and is subject to the safe harbor created by those
sections. Certain factors that realistically could cause results to differ
materially from those projected in the company’s forward-looking statements
are set forth in the company’s Annual Report on Form 10-K and Quarterly
Reports on Form 10-Q, as filed with the Securities and Exchange Commission.